RCHT led the way in groundbreaking SUPERNOVA trial

The SUPERNOVA trial has published its results. The important research investigated a drug called sipavibart to determine if it could protect immunocompromised individuals from COVID-19 infection and severe illness.

Text Size

Change font

Contrast